Welldorm
Welldorm contains chloral betaine, a sedative and hypnotic drug. It is a prodrug that metabolizes into active trichloroethanol in the body, which acts on the central nervous system to induce sleep. Due to concerns over dependence, tolerance, and toxicity, its use is strictly restricted to short-term management of severe, disabling insomnia.
Dosage by Body Weight
Adults: 1 to 2 tablets (707 mg to 1414 mg) at night, taken 15 to 30 minutes before bedtime with water or milk. Maximum duration of treatment is usually 2 weeks. It is not recommended for children and adolescents under 18 years of age unless initiated by a specialist.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Contraindicated in neonates and young infants due to risk of drug accumulation and respiratory depression.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in this age and weight group.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Standard tablets are not suitable for children. Specialist guidance required if alternative chloral derivatives are used.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Only to be used under strict specialist supervision in exceptional circumstances.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Welldorm tablets are not formulated for pediatric use; safety profiling is restricted.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Contraindicated in neonates and young infants due to risk of drug accumulation and respiratory depression. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established in this age and weight group. |
| 8-10 kg | Not recommended | Do not use | Standard tablets are not suitable for children. Specialist guidance required if alternative chloral derivatives are used. |
| 11-15 kg | Not recommended | Do not use | Only to be used under strict specialist supervision in exceptional circumstances. |
| 16-20 kg | Not recommended | Do not use | Welldorm tablets are not formulated for pediatric use; safety profiling is restricted. |
Formulation
Purpose
Short-term treatment of severe insomnia, especially in cases where other therapies have failed or are inappropriate.
Generic Name
Chloral betaineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.